Suchergebnisse - Rhamy Zeid
- Treffer 1 - 12 von 12
-
1
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition von Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe, Christopher F. Bassil, Jun Qi, Yvan H. Chanthery, Erin A. Nekritz, Rhamy Zeid, W. Clay Gustafson, Patricia Greninger, Matthew J. Garnett, Ultan McDermott, Cyril H. Benes, Andrew L. Kung, William A. Weiss, James E. Bradner, Kimberly Stegmaier
Veröffentlicht 2013Artigo -
2
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis von Jingwei Cheng, Donglim Esther Park, Christian Berrios, Elizabeth White, Reety Arora, Rosa Yoon, Timothy B. Branigan, Tengfei Xiao, Thomas Westerling, Alexander Federation, Rhamy Zeid, Benjamin J. Strober, Selene K. Swanson, Laurence Florens, James E. Bradner, Myles Brown, Peter M. Howley, Megha Padi, Michael P. Washburn, James A. DeCaprio
Veröffentlicht 2017Artigo -
3
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma von Rhamy Zeid, Matthew A. Lawlor, Evon Poon, Jaime M. Reyes, Mariateresa Fulciniti, Michael Lopez, Thomas G. Scott, Behnam Nabet, Michael A. Erb, Georg E. Winter, Zoe Jacobson, Donald R. Polaski, Kristen L. Karlin, Rachel Hirsch, Nikhil Munshi, Thomas F. Westbrook, Louis Chesler, Charles Y. Lin, James E. Bradner
Veröffentlicht 2018Artigo -
4
Transcription control by the ENL YEATS domain in acute leukaemia von Michael A. Erb, Thomas G. Scott, Bin E. Li, Huafeng Xie, Joshiawa Paulk, Hyuk‐Soo Seo, Amanda Souza, Justin M. Roberts, Shiva Dastjerdi, Dennis L. Buckley, Neville E. Sanjana, Ophir Shalem, Behnam Nabet, Rhamy Zeid, Nana K. Offei-Addo, Sirano Dhe‐Paganon, Feng Zhang, Stuart H. Orkin, Georg Winter, James E. Bradner
Veröffentlicht 2017Artigo -
5
Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes von Kenneth L. Scott, Cristina Nogueira, Timothy P. Heffernan, Remco van Doorn, Sabin Dhakal, Jason A. Hanna, Chengyin Min, Mariela Jaskelioff, Yonghong Xiao, Chang‐Jiun Wu, Lisa Cameron, Samuel R. Perry, Rhamy Zeid, Tamar Feinberg, Minjung Kim, George Vande Woude, Scott R. Granter, Marcus Bosenberg, Gerald C. Chu, Ronald A. DePinho, David L. Rimm, Lynda Chin
Veröffentlicht 2011Artigo -
6
BET Bromodomain Inhibition of<i>MYC</i>-Amplified Medulloblastoma von Pratiti Bandopadhayay, Guillaume Bergthold, Brian T. Nguyen, Simone Schubert, Sharareh Gholamin, Yujie Tang, Sara Bolin, Steven E. Schumacher, Rhamy Zeid, Sabran Masoud, Furong Yu, Nujsaubnusi Vue, William J. Gibson, Brenton R. Paolella, Siddhartha S. Mitra, Samuel Cheshier, Jun Qi, Kun-Wei Liu, Robert J. Wechsler‐Reya, William A. Weiss, Fredrik J. Swartling, Mark W. Kieran, James E. Bradner, Rameen Beroukhim, Yoon‐Jae Cho
Veröffentlicht 2013Artigo -
7
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment von Georg Winter, Andreas Mayer, Dennis L. Buckley, Michael A. Erb, Justine E. Roderick, Sarah Vittori, Jaime M. Reyes, Julia di Iulio, Amanda Souza, Christopher J. Ott, Justin M. Roberts, Rhamy Zeid, Thomas G. Scott, Joshiawa Paulk, Kate C Lachance, Calla M. Olson, Shiva Dastjerdi, Sophie Bauer, Charles Y. Lin, Nathanael S. Gray, Michelle A. Kelliher, L. Stirling Churchman, James E. Bradner
Veröffentlicht 2017Artigo -
8
Active medulloblastoma enhancers reveal subgroup-specific cellular origins von Charles Y. Lin, Serap Erkek, Yiai Tong, Linlin Yin, Alexander Federation, Marc Zapatka, Parthiv Haldipur, Daisuke Kawauchi, Thomas S. Risch, Hans-Jörg Warnatz, Barbara C. Worst, Bensheng Ju, Brent A. Orr, Rhamy Zeid, Donald R. Polaski, Maia Segura‐Wang, Sebastian M. Waszak, David Jones, Marcel Kool, Volker Hovestadt, Ivo Buchhalter, Laura Sieber, Pascal D. Johann, Lukas Chávez, Stefan Gröschel, Marina Ryzhova, Andrey Korshunov, Wenbiao Chen, Victor V. Chizhikov, Kathleen J. Millen, Vyacheslav Amstislavskiy, Hans Lehrach, Marie-Laure Yaspo, Roland Eils, Peter Lichter, Jan O. Korbel, Stefan M. Pfister, James E. Bradner, Paul A. Northcott
Veröffentlicht 2016Artigo -
9
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer von Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge, Rhamy Zeid, Isaac S. Harris, Bojana Jovanović, Katherine Murphy, Binbin Wang, Xintao Qiu, Jennifer E. Endress, Jaime M. Reyes, Klothilda Lim, Alba Font‐Tello, Sudeepa Syamala, Tengfei Xiao, Chandra Sekhar Reddy Chilamakuri, Evangelia K. Papachristou, Clive S. D’Santos, Jayati Anand, Kunihiko Hinohara, Wei Li, Thomas O. McDonald, Adrienne Luoma, Rebecca Modiste, Quang‐Dé Nguyen, Brittany C. Michel, Paloma Cejas, Cigall Kadoch, Jacob D. Jaffe, Kai W. Wucherpfennig, Jun Qi, X. Shirley Liu, Henry W. Long, Myles Brown, Jason S. Carroll, Joan S. Brugge, James E. Bradner, Franziska Michor, Kornélia Polyák
Veröffentlicht 2020Artigo -
10
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma von Evon Poon, Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert, Karen Barker, Zuzanna Urban‐Wójciuk, Khin Thway, Rhamy Zeid, Albert Hallsworth, Gary Box, Marli E. Ebus, Marco P. Licciardello, Yordan Sbirkov, Glori Lazaro, Elizabeth Calton, Barbara Martins Da Costa, Melanie Valenti, Alexis de Haven Brandon, Hannah Webber, Nicolas Tardif, Gilberto S. Almeida, Rossitza Christova, Gunther Boysen, Mark W. Richards, Giuseppe Barone, Anthony M. Ford, Richard Bayliss, Paul A. Clarke, Johann S. de Bono, Nathanael S. Gray, Julian Blagg, Simon P. Robinson, Suzanne A. Eccles, Daniella Zheleva, James E. Bradner, Jan J. Molenaar, Igor Vivanco, Martin Eilers, Paul Workman, Charles Y. Lin, Louis Chesler
Veröffentlicht 2020Artigo -
11
Melanoma genome sequencing reveals frequent PREX2 mutations von Michael F. Berger, Eran Hodis, Timothy P. Heffernan, Yonathan Lissanu Deribe, Michael S. Lawrence, Alexei Protopopov, Elena Ivanova, Ian R. Watson, Elizabeth Nickerson, Papia Ghosh, Hailei Zhang, Rhamy Zeid, Xiaojia Ren, Kristian Cibulskis, Andrey Sivachenko, Nikhil Wagle, Antje Sucker, Carrie Sougnez, Robert C. Onofrio, Lauren Ambrogio, Daniel Auclair, Timothy R. Fennell, Scott L. Carter, Yotam Drier, Petar Stojanov, Meredith A. Singer, Douglas Voet, Rui Jing, Gordon Saksena, Jordi Barretina, Alex H. Ramos, Trevor J. Pugh, Nicolas Stransky, Melissa Parkin, Wendy Winckler, Scott Mahan, Kristin Ardlie, Jennifer Baldwin, Jennifer A. Wargo, Dirk Schadendorf, Matthew Meyerson, Stacey Gabriel, Todd R. Golub, Stephan N. Wagner, Eric S. Lander, Gad Getz, Lynda Chin, Levi A. Garraway
Veröffentlicht 2012Artigo -
12
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism von Pratiti Bandopadhayay, Lori Ramkissoon, Payal Jain, Guillaume Bergthold, Jeremiah A. Wala, Rhamy Zeid, Steven E. Schumacher, Laura M. Urbanski, Ryan O’Rourke, William J. Gibson, Kristine Pelton, Shakti Ramkissoon, Harry Han, Yuankun Zhu, Namrata Choudhari, Amanda Silva, Katie Boucher, Rosemary E. Henn, Yun Jee Kang, David Knoff, Brenton R. Paolella, Adrianne Gladden-Young, Pascale Varlet, Mélanie Pagès, Peleg Horowitz, Alexander Federation, Hayley Malkin, Adam Tracy, Sara Seepo, Matthew D. Ducar, Paul Van Hummelen, Mariarita Santi, Anna Maria Buccoliero, Mirko Scagnet, Daniel C. Bowers, Caterina Giannini, Stéphanie Puget, Cynthia Hawkins, Uri Tabori, Álmos Klekner, László Bognár, Peter C. Burger, Charles G. Eberhart, Fausto J. Rodríguez, D. Ashley Hill, Sabine Mueller, Daphne A. Haas‐Kogan, Joanna J. Phillips, Sandro Santagata, Charles D. Stiles, James E. Bradner, Nada Jabado, Alon Goren, Jacques Grill, Azra H. Ligon, Liliana Goumnerova, Angela J. Waanders, Phillip B. Storm, Mark W. Kieran, Keith L. Ligon, Rameen Beroukhim, Adam Resnick
Veröffentlicht 2016Revisão
Suchwerkzeuge:
Ähnliche Schlagworte
Biology
Genetics
Gene
Cancer research
Gene expression
Promoter
Transcription factor
Cancer
Chromatin
Enhancer
Epigenetics
BRD4
Bromodomain
BET inhibitor
Cell culture
Neuroblastoma
Apoptosis
CRISPR
Carcinogenesis
Cell biology
Chromatin immunoprecipitation
Computational biology
Linguistics
Medulloblastoma
Melanoma
Molecular biology
P-TEFb
Pediatric cancer
Philosophy
RNA polymerase II